In summary, we demonstrated that the nasal priming with peptidoglycan from L. rhamnosus CRL1505 differentially modulates the respiratory innate antiviral immune response triggered by TLR3 activation in infant mice, improving the resistance to primary RSV infection, and secondary pneumococcal pneumonia. The gene discussed is TLR3; the disease is pneumococcal pneumonia.